Back to search

Article

B Lymphocyte Protein Factories produced by Hematopoietic Stem Cell Gene Editing

2026-01-18

Abstract excerpt

Long-term in vivo production of therapeutic proteins and development of vaccines that elicit protective levels of broadly neutralizing antibodies (bNAbs) against major pathogens face challenges. Here we report on an alternative gene-editing approach using small numbers of hematopoietic stem and progenitor cells (HSPCs) to direct long-term, high-level expression of antibodies or cargo proteins. Edited B lymphocyte...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
62c04f05-249c-5d99-8bf4-d36c3a21fb41
DOI
10.64898/2026.01.16.699998
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
B Lymphocyte Protein Factories produced by Hematopoietic Stem Cell Gene EditingDOI 10.64898/2026.01.16.699998
Select a neighboring publication to make it the new centre.